Sign In
Buy IMNN
$2.10
-0.0400 (-1.87%)
At Close: Jun 03, 2026
If You Had Bought Celsion (NASDAQ:CLSN) Stock Five Years Ago, You'd Be Sitting On A 97% Loss, Today
02:04pm, Friday, 17'th Apr 2020
Celsion Corporation (NASDAQ:CLSN) shareholders will doubtless be very grateful to see the share price up 63% in the...
Dublin, April 17, 2020 -- The "Nucleic Acid Based Gene Therapy Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering. The.
Celsion Corporation (CLSN), an oncology drug-development company, announces that the prescribed minimum number of events of 158 patient deaths has been reached for the second pre-specified interim ana
UPDATE: Celsion Says Independent Data Monitoring Committee Expected To Meet In Jul. 2020 To Conduct Second Interim Analysis
12:00am, Wednesday, 15'th Apr 2020Celsion (CLSN) Receives a Buy from Oppenheimer
03:11am, Friday, 27'th Mar 2020
In a report released yesterday, Hartaj Singh from Oppenheimer maintained a Buy rating on Celsion (CLSN), with a price target of $9.00. The company's
Celsion (CLSN) Receives a Buy from Oppenheimer
03:10am, Friday, 27'th Mar 2020
In a report released yesterday,
Hartaj Singh
from Oppenheimer maintained a
Buy
rating on Celsion (
CLSN
–
Research Report
), with a price target of
$9.00
. The company’s shares closed last Monday
Edited Transcript of CLSN earnings conference call or presentation 26-Mar-20 3:00pm GMT
01:39am, Friday, 27'th Mar 2020
Q4 2019 Celsion Corp Earnings Call
Celsion Corp. to Host Earnings Call
01:00pm, Thursday, 26'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 26, 2020 / Celsion Corp. (NASDAQ:CLSN) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 26, 2020 at 11:00 AM E
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 25.)
Ra Pharmaceuticals Inc (...
Celsion Corporation (CLSN), a leading oncology drug development company, today jointly announced with Medidata, a Dassault Systèmes company, that examining matched patient data provided by Medidata i
Celsion Corporation Reports 2019 Financial Results and Provides Business Update
08:15pm, Wednesday, 25'th Mar 2020
Enters 2020 with a Strong Balance Sheet and an Advancing Clinical Pipeline Conference Call Begins at 11:00 a.m. Eastern Time on Thursday March 26, 2020.
Celsion Q4 EPS $(0.77) Down From $(0.68) YoY, Sales $500K, Same YoY
12:00am, Wednesday, 25'th Mar 2020Celsion’s GEN-1 Immunotherapy Receives Orphan Drug Designation from the European Medicines Agency
12:00pm, Monday, 23'rd Mar 2020
Celsion Corporation (CLSN), a leading oncology drug development company, today announced the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has recommended that GEN-1 b
